• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Landmark Study Reveals Clearest Genetic Signals Yet for Schizophrenia Risk

by William Jester | May 11, 2022 | Community, News

In a landmark genetic study of more than 121,000 people, Rutgers and an international consortium of researchers have identified extremely rare protein-disrupting mutations in 10 genes that strongly increase an individual’s risk of developing schizophrenia. The Genomic...

An Overview of NORD and How It May Be Helpful to You – Webinar May 17th

by Pamela Dahlen | May 10, 2022 | Community, News

ResearchMatch is pleased to continue our collaboration with the National Organization for Rare Disorders (NORD) on this free informational webinar. You are invited to join us tomorrow, May 17th, at 1 pm ET/12 pm CT for an overview of NORD, with linkages to essential...

Nanoparticles Can Cross the Placenta During Pregnancy, Potentially Exposing Fetus.

by William Jester | May 10, 2022 | Community, News

Inhaled nanoparticles – human-made specks so minuscule they can’t be seen in conventional microscopes, found in thousands of common products – can cross a natural, protective barrier that normally protects fetuses, according to Rutgers University scientists studying...

Many Physicians Have Misconceptions About E-Cigarettes.

by William Jester | May 9, 2022 | Community, News

Many physicians incorrectly believe all tobacco products are equally harmful and thus are less likely to recommend e-cigarettes for people seeking to quit smoking or those being treated for a tobacco-caused disease, according to a Rutgers study. About 480,000 people...

COVID’s other toll: Mental health of nurses

by Pamela Dahlen | May 7, 2022 | Community, Covid, News

Hospitals working to help staff who struggled with anxiety, racism, fear while pandemic raged While COVID-19 cases have declined significantly in recent months, the pandemic has taken a heavy toll on the mental health of nurses and other frontline providers. A Rutgers...
« Older Entries
Next Entries »

Recent Posts

  • Join NCATS on 10/9 for the Director’s Roundtable
  • Mentoring Biomedical Graduate Students and Postdocs – Workshop 10/9
  • NJ ACS Community Event on 10/13 from 10:30 – 12:00
  • NJ ACTS Special Populations Seminar 9/29 – Register Now
  • NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25

Archives

  • 2026
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,502)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,178)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.